MSc Clinical Pharmacy

Year of entry: 2024

Course unit details:
Specialist Medicines Optimisation and Therapeutics

Course unit fact file
Unit code PHAR63021
Credit rating 15
Unit level FHEQ level 7 – master's degree or fourth year of an integrated master's degree
Teaching period(s) Semester 1
Available as a free choice unit? No

Overview

This module builds upon the knowledge and skills gained in prior units to further develop the student’s professional practice in managing patients with complex disease states, including those with HIV, TB, cancer, and patients requiring intensive care, clinical nutrition or biological therapies.

Depending on the student’s area of practice there will be an opportunity to choose appropriate case studies to meet their professional needs.

At the end of the unit the student should be able to:

  • apply a considered, systematic approach to problem solving for patients with advanced disease states
  • critically apply the evidence available in the treatment of advanced disease states
  • evaluate the key therapeutic principles of treating advanced disease states and demonstrate how they can be incorporated into practice
  • demonstrate a working knowledge of the principles of individualising patient care within specific advanced disease states
  • identify how to monitor the desired outcomes and adverse effects of drug therapy
  • discuss the complexities of therapeutic decision making in different advanced disease states and patient groups
  • apply the principles of Continuing Professional Development to practice and evaluating their competence against a professional competency framework.

Pre/co-requisites

Unit title Unit code Requirement type Description
Foundations of Clinical Pharmacy PHAR63001 Pre-Requisite Compulsory
Evidence Based Practice PHAR63002 Pre-Requisite Compulsory
PHAR63011 Pre-Requisite Compulsory
Medicines Optimisation and Therapeutics 2 PHAR63012 Pre-Requisite Compulsory

Aims

The unit aims to further develop the knowledge and skills required to engage in medicines optimisation and engage in clinical problem solving skills in complex disease states including the critical care patient and advanced and complex disease states (HIV, TB, nutrition, cancer, critical care and biological therapies).

Students will apply this knowledge to review patients and optimise their therapy through a series of case study and wiki exercises.

Teaching and learning methods

Online Option

This course unit is delivered online using Blackboard 10. All learning material is presented in week by week folders to help students manage their time. Each week will contain four main elements; background reflective tasks, learning in the form of an e-lecture, embedded video or webinar, further reading and finally a task to consolidate learning (e.g. completion of coursework, formative quiz or participation in a group discussion). Students will be given the option to choose from a range of complex disease states to study to enhance their own expertise relevant to their current role or future career aspirations.

This unit builds upon the knowledge and skills gained in prior units to further develop the student’s professional practice in managing patients with complex, advanced disease states, including those with HIV, TB, Cancer, and patients requiring intensive care, clinical nutrition and biological therapies.

This will provide the following outcomes:

  • critical evaluation of primary and secondary evidence, local and national guidelines relating these to the individual patient needs
  • develop the student’s decision making and problem solving skills with regards to patient care
  • medicines optimisation issues including patient safety and wastage of medicines, which will include relevant national policy and guidelines
  • patient-centred care including patient and health care professional communication and consultation skills
  • encourage a holistic approach to patient care which accounts for the personal, social and cultural needs of the patient.

 

Depending on the student’s area of practice there will be an opportunity to choose appropriate case studies to meet their professional needs.

The on-line and face to face workshops and tutorials included in the course allow students the opportunities to broaden knowledge and provide the opportunity for group discussion of more complex disease states and practice-related issues regarding medicines optimisation.  The unit will foster an online student community with interactive activities and communications with the unit team

Blended Option

The unit will be delivered using a blended learning approach providing students with a structured on-line learning programme complemented by study days. The study days will consist of application workshops delivered by expert clinical specialists, thus providing the students a unique learning experience. Workshops will be interactive and will normally utilise a case study to illustrate the major therapeutic issues outlined in the learning objectives. They will also provide an opportunity to develop the student’s communication and consultation skills.

Knowledge and understanding

  • Demonstrate a systematic understanding of specific disease states (HIV/TB, nutrition, critical care, biologic therapies and cancer) and the complex issues involved in therapeutic optimisation and individualising care for patients with these diseases.
  • Demonstrate an advanced knowledge of best clinical practice and its application to clinical practice and pharmaceutical care of patients with specific disease states (as above).

Intellectual skills

  • Integrate theory and research of disease pathology and disease management with patient information to apply best evidence to practice in a clinical problem-solving context.
  • Use critical reasoning to synthesise, analyse and evaluate primary and secondary sources of data from clinical areas and apply these to individual patient problem-solving.

Practical skills

  • Safely and competently carry out a range of patient-based clinical skills (pharmaceutical care planning, case-based analysis of patient management).
  • Use resources to collect and select information about the optimal clinical management of a complex patient.
  • Develop presentation skills.
  • Carry out constructive peer review.

Transferable skills and personal qualities

  • Learn to manage effective team working by carrying out tasks within a small group in a structured situation, and by preparing and giving an oral presentation [blended only].
  • Evaluate their own academic and personal progression.
  • Learn effectively for the purpose of continuing professional development and in a wider context throughout their career, including demonstrating competency against a professional competency framework.

Assessment methods

Case analysis

  • 2,000 words
  • Combined with oral presentation for total 70% weighting of overall unit mark (70% of this component is weighted from case analysis, 30% oral presentation).

Oral presentation and defence of case analysis

  • 20 mins
  • Combined with case analysis for total 70% weighting of overall unit mark (30% of this component is for the oral presentation, 70% case analysis).

Pharmaceutical care plan

  • 2,000 words
  • 30% weighting of overall unit mark.

 

Feedback methods

Provisional marks and feedback for coursework returned within 15 working days.

Exam marks and final marks returned after ratification at exam board. 

Recommended reading

Please see link to extensive list below:

https://manchester.alma.exlibrisgroup.com/leganto/readinglist/lists/323050295990001631

Use of inotropes in critical care – Berry W and Mckenzie C. Clinical Pharmacist 2010 , 2,  395-396

Smith G, Nielsen M.  ABC of intensive care: Criteria for Admission BMJ 1999; 318: 1544 –1547

Greater Manchester & Cheshire Cancer Network Symptom Control guidelines http://www.gmccn.nhs.uk/hp/portal_repository/files/MASTERNETWORKJULY2011SymptomControlGuidancewebsite.pdf

Weston R, Marett B. HIV Infection – pathology and disease progression. Clinical Pharmacist 2009; 1: 393-399

Weston R, Marett B. HIV Infection – combination antiretroviral therapy. Clinical Pharmacist 2009; 1: 387-392

Tuberculosis: NICE Guidance. 

http://guidance.nice.org.uk/CG117

Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition NICE guidelines [CG32]

https://www.nice.org.uk/guidance/CG32

Study hours

Scheduled activity hours
eAssessment 20
Lectures 2
Seminars 5
Tutorials 2
Independent study hours
Independent study 121

Teaching staff

Staff member Role
Caroline Templeton Unit coordinator

Return to course details